Covalon Technologies Operating Income 2013-2025 | CVALF
Covalon Technologies operating income from 2013 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Covalon Technologies Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $1 |
| 2024 | $2 |
| 2023 | $-3 |
| 2022 | $-7 |
| 2021 | $1 |
| 2020 | $-5 |
| 2019 | $-6 |
| 2018 | $1 |
| 2017 | $1 |
| 2016 | $-2 |
| 2015 | $-1 |
| 2014 | $2 |
| 2013 | $4 |
|
Covalon Technologies Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $0 |
| 2025-06-30 | $0 |
| 2025-03-31 | $0 |
| 2024-12-31 | $1 |
| 2024-09-30 | $0 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-2 |
| 2023-06-30 | $0 |
| 2023-03-31 | $-1 |
| 2022-12-31 | $0 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-1 |
| 2022-03-31 | $-2 |
| 2021-12-31 | $-1 |
| 2021-09-30 | $-1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $0 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $0 |
| 2018-12-31 | $-1 |
| 2018-09-30 | $0 |
| 2018-06-30 | $2 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $-2 |
| 2016-06-30 | $0 |
| 2016-03-31 | $-1 |
| 2015-12-31 | $0 |
| 2015-09-30 | $-1 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | $-1 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $3 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $1 |
| 2012-12-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.034B | $0.023B |
| Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies. The company's patented technologies, product and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Its technologies are used to prevent, detect and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care and medical device coatings. Covalon Technologies Ltd. is based in Mississauga, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $205.422B | 23.91 |
| Intuitive Surgical (ISRG) | United States | $175.022B | 67.51 |
| IDEXX Laboratories (IDXX) | United States | $51.088B | 48.95 |
| Edwards Lifesciences (EW) | United States | $44.567B | 29.88 |
| Alcon (ALC) | Switzerland | $38.798B | 26.15 |
| IQVIA Holdings (IQV) | United States | $32.812B | 17.73 |
| Mettler-Toledo (MTD) | United States | $28.067B | 32.27 |
| DexCom (DXCM) | United States | $27.364B | 37.72 |
| STERIS (STE) | Ireland | $24.068B | 24.34 |
| Waters (WAT) | United States | $19.540B | 24.99 |
| Coloplast (CLPBY) | Denmark | $17.286B | 26.45 |
| Hologic (HOLX) | United States | $16.748B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.942B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.849B | 11.49 |
| Penumbra (PEN) | United States | $13.278B | 93.40 |
| Globus Medical (GMED) | United States | $11.723B | 24.60 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.241B | 23.20 |
| Glaukos (GKOS) | United States | $6.506B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.150B | 19.54 |
| Teleflex (TFX) | United States | $4.694B | 7.48 |
| TransMedics (TMDX) | United States | $4.659B | 55.20 |
| LivaNova (LIVN) | United Kingdom | $3.590B | 19.39 |
| Integer Holdings (ITGR) | United States | $2.994B | 14.06 |
| Veracyte (VCYT) | United States | $2.903B | 33.09 |
| Elekta AB (EKTAY) | Sweden | $2.276B | 21.29 |
| UFP Technologies (UFPT) | United States | $2.047B | 27.03 |
| Alphatec Holdings (ATEC) | United States | $2.007B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.918B | 21.17 |
| Artivion (AORT) | United States | $1.877B | 86.11 |
| Pulse Biosciences (PLSE) | United States | $1.641B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.632B | 0.00 |
| AxoGen (AXGN) | United States | $1.565B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.281B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.937B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.851B | 4.61 |
| SiBone (SIBN) | United States | $0.668B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.661B | 13.19 |
| Alpha Tau Medical (DRTS) | Israel | $0.654B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.611B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.610B | 35.46 |
| Pacific Biosciences Of California (PACB) | United States | $0.556B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.517B | 0.00 |
| NeuroPace (NPCE) | United States | $0.508B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.502B | 13.07 |
| AngioDynamics (ANGO) | United States | $0.440B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.401B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.351B | 58.53 |
| RxSight (RXST) | United States | $0.340B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.314B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.285B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.231B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.184B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.169B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.155B | 0.00 |
| Inogen (INGN) | United States | $0.152B | 0.00 |
| LENSAR (LNSR) | United States | $0.148B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.141B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.124B | 0.00 |
| Hyperfine (HYPR) | United States | $0.111B | 0.00 |
| Neuronetics (STIM) | United States | $0.102B | 0.00 |
| Solana (HSDT) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.081B | 0.00 |
| Positron (POSC) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| DarioHealth (DRIO) | United States | $0.070B | 0.00 |
| Accuray (ARAY) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.064B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.041B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.027B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |